Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Laura Franzke"'
Autor:
Stacey W. Martin, Yujia Zhang, Michael M. McNeil, Charles E. Rose, Brock Stewart, Jerome I. Tokars, Laura Franzke
Publikováno v:
Vaccine. 30:1841-1846
Background In 2002 CDC initiated the Anthrax Vaccination Program (AVP) to provide voluntary pre-exposure vaccination with Anthrax Vaccine Adsorbed (AVA) for persons at high risk of exposure to Bacillus anthracis spores. There has been concern that AV
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d3c3cd2f482cacb52cc939d162f78a4
https://doi.org/10.1016/j.vaccine.2011.12.128
https://doi.org/10.1016/j.vaccine.2011.12.128
Autor:
Stacey W. Martin, Yujia Zhang, Laura Franzke, Shirley A. Robertson, Jerry P. Smith, Charles E. Rose, Deborah L. Sammons, Raymond E. Biagini, Michael M. McNeil
Publikováno v:
Pharmacoepidemiology and Drug Safety. 17:1060-1067
Background In 2002, CDC initiated the Anthrax Vaccination Program (AVP) to provide voluntary pre-exposure anthrax vaccination for individuals at high risk for exposure to Bacillus anthracis spores. The AVP offered an opportunity to investigate hypoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::acda97175eec43e1513e6437047fb3e3
https://doi.org/10.1002/pds.1657
https://doi.org/10.1002/pds.1657
Autor:
John L. Sever, Nina Marano, Randy D. Louchart, Joyce A. Goff, Laura Franzke, Dori B. Reissman, Bruce C. Tierney, Michael M. McNeil, Stacey Martin, Nancy E. Rosenstein
Publikováno v:
Clinical Infectious Diseases. 37:905-911
On 20 December 2001, the Centers for Disease Control and Prevention (CDC) initiated the Anthrax Vaccine and Antibiotic Availability Program (hereafter, the "Program") under an investigational new drug application with the US Food and Drug Administrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08f20e213f3895dd0452baf65afefe14
https://doi.org/10.1086/377738
https://doi.org/10.1086/377738
Publikováno v:
Health Informatics ISBN: 9781447142362
Evaluation is the application of specific criteria to determine the value or merit of the object of the study. Ensuring that public health information systems (ISs) and programs are managed wisely is essential. Evaluation answers the question of “w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::575b7fe7b9174cb7e7cbc4cf6efed382
https://doi.org/10.1007/978-1-4471-4237-9_13
https://doi.org/10.1007/978-1-4471-4237-9_13
Publikováno v:
Pharmacoepidemiology and drug safety. 16(1)
Purpose In 2002, the Centers for Disease Control and Prevention established the Vaccine Analytic Unit (VAU) in collaboration with the Department of Defense (DoD). The focus of this report is to describe the process by which the VAU's anthrax vaccine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfe28586962004d575fbd4e8f0718f22
https://pubmed.ncbi.nlm.nih.gov/16444796
https://pubmed.ncbi.nlm.nih.gov/16444796
Autor:
Stacey W. Martin, Bruce C. Tierney, Louis Apicella, Michael M. McNeil, Aaron Aranas, Laura Franzke, Nancy E. Rosenstein, Nina Marano
Publikováno v:
Pharmacoepidemiology and drug safety. 14(6)
Purpose The CDC's Anthrax Vaccine and Antibiotic Availability Program was implemented under an Investigational New Drug (IND) application to provide additional post-exposure prophylaxis for individuals potentially exposed to Bacillus anthracis in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f934fd2ee3d7e68858f96af422e5668
https://pubmed.ncbi.nlm.nih.gov/15924332
https://pubmed.ncbi.nlm.nih.gov/15924332